Hemorrhage – severe heavy bleeding – and hypertensive disorders like preeclampsia are the leading causes of maternal deaths globally, according to a new study released today by the World Health Organization (WHO).
Novo Nordisk expands site to manufacture GLP-1 drugs – Pharmaceutical Technology
Share this article A total of 500 new jobs will be created with this investment as per the press release. Credit: JHVEPhoto via www.shutterstock.com. Novo